Arcadia Biosciences Inc logo

RKDA - Arcadia Biosciences Inc Share Price

$2.69 -0.0  -0.7%

Last Trade - 05/03/21

Sector
Basic Materials
Size
Micro Cap
Market Cap £41.5m
Enterprise Value £37.0m
Revenue £954k
Position in Universe 5413th / 6651
Bullish
Bearish
Unlock RKDA Revenue
Momentum
Relative Strength (%)
1m -8.79%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -58.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
6.98 5.41 3.19 4.03 1.46 1.17 1.99 12.3 -30.1%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2020, ArcadiaBiosciences Inc revenues increased 20% to $904K. Net lossdecreased 40% to $13.6M. Revenues reflect Product increaseof 30% to $630K, License increase from $17K to $110K. Lowernet loss reflects Change in fair value of common stock warincrease from $6.8M (expense) to $6.2M (income), Researchand development - Balancing decrease of 69% to $1.7M(expense), Selling.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

RKDA Revenue Unlock RKDA Revenue

Net Income

RKDA Net Income Unlock RKDA Revenue

Normalised EPS

RKDA Normalised EPS Unlock RKDA Revenue

PE Ratio Range

RKDA PE Ratio Range Unlock RKDA Revenue

Dividend Yield Range

RKDA Dividend Yield Range Unlock RKDA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
RKDA EPS Forecasts Unlock RKDA Revenue
Profile Summary

Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market. Its crop yield traits are utilized by its partners to develop higher yielding seeds for global crops, including wheat, rice, soybean, corn, and sugarcane, as well as for other crops, such as cotton, turf and trees. The Company's portfolio of agricultural productivity traits includes Nitrogen Use Efficiency (NUE), Water Use Efficiency (WUE), Drought Tolerance (DT), Salinity Tolerance (ST) and Herbicide Tolerance. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada.

Directors
Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated February 17, 2015
Public Since May 15, 2015
No. of Shareholders: 36
No. of Employees: 41
Sector Basic Materials
Industry Chemicals
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 21,327,645
Free Float (0.0%)
Eligible for
ISAs
SIPPs
RKDA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for RKDA
Upcoming Events for RKDA
Frequently Asked Questions for Arcadia Biosciences Inc
What is the Arcadia Biosciences Inc share price?

As of 05/03/21, shares in Arcadia Biosciences Inc are trading at $2.69, giving the company a market capitalisation of £41.5m. This share price information is delayed by 15 minutes.

How has the Arcadia Biosciences Inc share price performed this year?

Shares in Arcadia Biosciences Inc are currently trading at $2.69 and the price has moved by -33.25% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Arcadia Biosciences Inc price has moved by -47.35% over the past year.

What are the analyst and broker recommendations for Arcadia Biosciences Inc?

Of the analysts with advisory recommendations for Arcadia Biosciences Inc, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Arcadia Biosciences Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Arcadia Biosciences Inc next release its financial results?

Arcadia Biosciences Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Arcadia Biosciences Inc dividend yield?

Arcadia Biosciences Inc does not currently pay a dividend.

Does Arcadia Biosciences Inc pay a dividend?

Arcadia Biosciences Inc does not currently pay a dividend.

When does Arcadia Biosciences Inc next pay dividends?

Arcadia Biosciences Inc does not currently pay a dividend.

How do I buy Arcadia Biosciences Inc shares?

To buy shares in Arcadia Biosciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Arcadia Biosciences Inc?

Shares in Arcadia Biosciences Inc are currently trading at $2.69, giving the company a market capitalisation of £41.5m.

Where are Arcadia Biosciences Inc shares listed? Where are Arcadia Biosciences Inc shares listed?

Here are the trading details for Arcadia Biosciences Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: RKDA
What kind of share is Arcadia Biosciences Inc?

Based on an overall assessment of its quality, value and momentum, Arcadia Biosciences Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Arcadia Biosciences Inc share price forecast 2021?

Shares in Arcadia Biosciences Inc are currently priced at $2.69. At that level they are trading at 0.142% discount to the analyst consensus target price of 0.00.

Analysts covering Arcadia Biosciences Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.82 for the next financial year.

How can I tell whether the Arcadia Biosciences Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Arcadia Biosciences Inc. Over the past six months, the relative strength of its shares against the market has been -22.28%. At the current price of $2.69, shares in Arcadia Biosciences Inc are trading at -18.81% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Arcadia Biosciences Inc PE Ratio?

We were not able to find PE ratio data for Arcadia Biosciences Inc.

Who are the key directors of Arcadia Biosciences Inc?

Arcadia Biosciences Inc's management team is headed by:

Donald Emlay - VPR
Zhongjin Lu - OTH
Peter Gajdos - DRC
Kevin Comcowich - CHM
Jamie Bechtel - DRC
Sarah Reiter - OTH
Albert Bolles - DRC
Lilian Shackleford Murray - DRC
Matthew Plavan - CEO
Pamela Haley - CFO
Kevin Hodges - VPR
Tracy Baker - VPR
Debbie Carosella - DRC
Who are the major shareholders of Arcadia Biosciences Inc?

Here are the top five shareholders of Arcadia Biosciences Inc based on the size of their shareholding:

Moral Compass Corporation Corporation
Percentage owned: 5.28% (1.13m shares)
Mandala Agribusiness Co-Investments I, Ltd. Corporation
Percentage owned: 2.13% (454k shares)
Armistice Capital LLC Hedge Fund
Percentage owned: 1.86% (396k shares)
Ardsley Advisory Partners LP Hedge Fund
Percentage owned: 1.41% (300k shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 1.24% (264k shares)
Similar to RKDA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.